Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page
- Check5 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding notice and Revision: v3.4.1 were removed. No study data, content, or user actions on the page were altered.SummaryDifference0.2%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center status was added at the top of the page. The revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedUI and metadata updates include a glossary toggle and revised update-tracking labels (Last Update Submitted that Met QC Criteria, Last Update Posted) with a new revision tag (Revision: v3.4.0), replacing older labels. These changes do not modify core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedPage revision metadata updated from v3.3.3 to v3.3.4. No changes to study content, eligibility criteria, locations, or results were observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedUpdated study locations with numerous new sites across the US, Australia, Canada, Japan, and other countries; the previous locations were removed. A new Revision: v3.3.3 tag was added.SummaryDifference1%

Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.